Tony Wu
American Association for Cancer Research (AACR)

Last Updated On 5/16/2023 4:04:30 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
Company: Zygosity Limited
Recipient: You

Leadership
Company: Zygosity Limited
Recipient: You

Stock and Other Ownership Interests
Company: Zygosity Limited
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
No Relationships to Disclose

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Genentech/Roche
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution
Company: Amgen
Recipient: Your Institution
Company: Merck
Recipient: Your Institution
Company: Bayer
Recipient: Your Institution
Company: Janssen
Recipient: Your Institution
Company: Boehringer Ingelheim
Recipient: Your Institution
Company: Bristol Myers Squibb
Recipient: Your Institution
Company: AstraZeneca
Recipient: Your Institution
Company: Pfizer
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: December 2020: PCT/GB2020/053295 (Dec 2019; GB1918692.3) Treatment and prognosis of pancreatic cancer March 2021: PCT/GB2021/050650 (March 2020; GB2003814.7) Optimising methods for cleavage of target sequences December 2021: 63/287,720 Gene editing compositions and methods thereof December 2021: 63/287,724 Gene editing compositions and methods thereof
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
No Relationships to Disclose